TWO SIGMA ADVISERS, LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,113,794
-60.7%
1,031,291
-53.0%
0.00%
-57.1%
Q2 2023$2,832,441
-9.3%
2,195,691
-7.2%
0.01%
-12.5%
Q1 2023$3,124,032
+15.8%
2,366,691
+31.6%
0.01%0.0%
Q4 2022$2,698,487
+17.4%
1,798,991
-7.7%
0.01%
+14.3%
Q3 2022$2,299,000
+544.0%
1,948,291
+517.3%
0.01%
+600.0%
Q2 2022$357,000
+130.3%
315,591
+509.4%
0.00%
Q1 2022$155,000
-89.7%
51,791
-90.9%
0.00%
-100.0%
Q4 2021$1,501,000
-77.2%
566,591
-68.8%
0.00%
-76.5%
Q3 2021$6,587,000
-20.5%
1,814,691
-5.0%
0.02%
-22.7%
Q2 2021$8,288,000
+2.3%
1,909,691
-19.4%
0.02%0.0%
Q1 2021$8,104,000
+544.2%
2,369,491
+559.1%
0.02%
+633.3%
Q4 2020$1,258,000
-49.4%
359,491
-65.3%
0.00%
-57.1%
Q3 2020$2,484,000
+58.6%
1,034,991
+20.9%
0.01%
+40.0%
Q2 2020$1,566,000
+24.1%
855,891
+5.8%
0.01%0.0%
Q1 2020$1,262,000
-25.0%
808,691
+2.8%
0.01%
+25.0%
Q4 2019$1,683,000
+34.6%
786,491
+17.7%
0.00%
+33.3%
Q3 2019$1,250,000
-14.9%
668,191
+18.8%
0.00%
-25.0%
Q2 2019$1,468,000
+11.5%
562,391
+9.8%
0.00%
+33.3%
Q1 2019$1,317,000
+230.9%
512,391
+196.2%
0.00%
+200.0%
Q4 2018$398,000
-40.7%
172,991
-17.2%
0.00%
-50.0%
Q3 2018$671,000
+50.1%
208,991
+32.2%
0.00%
+100.0%
Q2 2018$447,000
-14.2%
158,091
+7.4%
0.00%0.0%
Q1 2018$521,000
+30.6%
147,191
+43.2%
0.00%0.0%
Q4 2017$399,000
+99.5%
102,791
+30.5%
0.00%0.0%
Q3 2017$200,000
-21.6%
78,791
-15.6%
0.00%0.0%
Q2 2017$255,000
-24.3%
93,391
-8.2%
0.00%0.0%
Q1 2017$337,000
-28.9%
101,691
-48.9%
0.00%
-50.0%
Q4 2016$474,000
-52.7%
199,191
-27.1%
0.00%
-50.0%
Q3 2016$1,002,000
+85.9%
273,091
+12.9%
0.00%
+33.3%
Q2 2016$539,000
-7.9%
241,891
-14.0%
0.00%0.0%
Q1 2016$585,000
-32.5%
281,191
-1.8%
0.00%
-40.0%
Q4 2015$867,000
+9.7%
286,291
-9.0%
0.01%0.0%
Q3 2015$790,000
-29.1%
314,491
-9.4%
0.01%
-44.4%
Q2 2015$1,114,000
+9.5%
346,991
+21.8%
0.01%
+12.5%
Q1 2015$1,017,000
+73.8%
284,791
+10.6%
0.01%
+60.0%
Q4 2014$585,000
+31.8%
257,491
+12.4%
0.01%
+66.7%
Q3 2014$444,000
-48.8%
228,991
-4.3%
0.00%
-57.1%
Q2 2014$868,000
+0.6%
239,191
+7.4%
0.01%
-12.5%
Q1 2014$863,000
+28.4%
222,691
-5.7%
0.01%
+33.3%
Q4 2013$672,000236,1910.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders